An international team of researchers has discovered the first DNA faults linked to melanoma - the deadliest skin cancer - that are not related to hair, skin or eye colour.
Cancer Research UK scientists at the University of Leeds, together with a team from the GenoMEL consortium*, scanned the genes in blood samples from almost 3000 Europeans with melanoma, and compared these with samples taken from the general population. Their findings are published in Nature Genetics today.**
Known risk factors for melanoma include fair skin, blue or green eyes, blond or red hair, a high number of moles, people who burn easily and those who have a family history.
Previous research by these and other scientists identified five pigmentation genes and three 'mole formation' genes, linked to melanoma risk. But the scientists have now discovered three new risk genes ¬- ¬not associated with pigmentation or moles***.
Four per cent of the UK population****, around 2.3m people, will carry two copies of all three gene faults (one copy inherited from each parent). The average risk of developing melanoma is about one in 60. This goes up to one in 46 if a person has both copies of all three gene faults.
Lead author, Professor Tim Bishop, based in the Cancer Research UK centre at the University of Leeds, said: "We know that overexposure to UV increases the risk of developing melanoma - but this evidence shows that there are new additional genetic faults which can push up the risk further.
"It is fascinating to discover these new melanoma risk factors - and we expect that the results of similar studies underway will reveal even more."
Dr Lesley Walker, Cancer Research UK's director of cancer information, said: "These intriguing results provide deeper understanding of the causes of melanoma and provide a potential new approach to identify people most at risk of developing melanoma and other cancers."
One DNA fault was found in the region of a gene called MX2 linked to narcolepsy - a disease thought to be triggered by the immune system which causes people to fall asleep spontaneously.
Another fault was found in a gene called ATM involved in DNA repair - preventing cancer-causing mistakes being passed onto daughter cells.
The third gene fault was found in the CASP8 gene, which plays a role in controlling cell spread by triggering automatic cell death.
There are around 11,770 new cases of malignant melanoma diagnosed each year in the UK and these are mainly caused by overexposure to UV light. Almost one third of all cases of malignant melanoma occur in people under 55. Over the last twenty-five years, rates of malignant melanoma in Britain have risen faster than any of the most common cancers.
Dr Lesley Walker added: "Cancer Research UK has invested heavily in research to identify tiny DNA changes to paint an overall picture of which regions of DNA could be linked to cancer - and we hope that research like this will reveal further genetic secrets to help us diagnose and treat the disease.
"The best way to reduce the risk of skin cancer, is to protect yourself from strong sun by covering up with clothing, spending some time in the shade, and applying at least SPF 15 sunscreen with four or more stars generously and regularly."
For more information:
Contact: Paula Gould, University of Leeds Communications & Press Office: Tel +44 (0) 113 343 8059, email firstname.lastname@example.org
Notes to editors:
*GenoMEL consortium brings together teams from around the world who are working on the genetics of melanoma and identifying who is prone to developing melanoma. www.genomel.org
**Genome-wide association study identifies three new melanoma susceptibility loci. Nature Genetics. Barrett et al. [doi:10.1038/10.1038/ng.959].
***The new discoveries brings the total to 11 known genetic variations linked to increased melanoma risk and could potentially help identify people at greater risk of developing the disease in the future.
****The estimated resident population in the UK was 62,262,000 in mid-2010 according to figures from the Office for National Statistics of whom 91 per cent have white skin; melanoma is very rare in persons with other than white skin.
About the Leeds Cancer Research UK Centre
The Leeds Cancer Research UK Centre represents a formal partnership between the University of Leeds, Leeds Teaching Hospitals NHS Trust and Cancer Research UK which aims to harness the scientific power of Leeds-based cancer researchers in order to deliver improvements in cancer therapy at local, national and international level.
About the University of Leeds
One of the UK's largest medical, health and bioscience research bases, the University of Leeds delivers world leading research in medical engineering, cancer, cardiovascular studies, epidemiology, molecular genetics, musculoskeletal medicine, dentistry, psychology and applied health. Treatments and initiatives developed in Leeds are transforming the lives of people worldwide with conditions such as diabetes, HIV, tuberculosis and malaria. www.leeds.ac.uk
About Cancer Research UK
Cancer Research UK is the world's leading cancer charity dedicated to saving lives through research
- The charity's groundbreaking work into the prevention, diagnosis and treatment of cancer has helped save millions of lives. This work is funded entirely by the public.
- Cancer Research UK has been at the heart of the progress that has already seen survival rates double in the last forty years.
- Cancer Research UK supports research into all aspects of cancer through the work of over 4,000 scientists, doctors and nurses.
- Together with its partners and supporters, Cancer Research UK's vision is to beat cancer.
For further information about Cancer Research UK's work or to find out how to support the charity, please call +44 (0)20 7121 6699 or visit www.cancerresearchuk.org